Risk factors and interventional strategies for BK polyomavirus infection after renal transplantation
- 28 September 2012
- journal article
- Published by Taylor & Francis Ltd in Scandinavian Journal of Urology and Nephrology
- Vol. 46 (6), 466-474
- https://doi.org/10.3109/00365599.2012.726643
Abstract
Objective. BK virus (BKV)-induced viraemia after renal transplantation can be associated with severe impairment of graft function. This study evaluated possible risk factors for BKV replication and examined the outcomes following various currently used treatment approaches. Material and methods. Fifty-seven renal transplant recipients with BKV viraemia were retrospectively compared with 71 BKV-negative recipients to identify risk factors for BKV viraemia. Furthermore, outcome and graft function in 14 patients with BKV replication, in whom mycophenolate mofetil (MMF) was discontinued with a dose reduction of the remaining immunosuppressants, were compared with 32 patients in whom both MMF and the additional immunosuppressants were reduced. Results. Patients with BKV viraemia received MMF (p < 0.01) and triple immunosuppression (p < 0.01) significantly more often, and displayed tacrolimus (p = 0.034) at higher blood concentrations (p = 0.002), a lower lymphocyte count (p = 0.006) and a longer warm ischaemic time (p = 0.019), and were more often male (p = 0.026). Patients in whom MMF was stopped had a higher chance of clearance of BKV viraemia (p = 0.022), which was achieved more rapidly (p = 0.048). Graft function improved during treatment and no graft losses occurred, compared with eight graft losses in the MMF-treated group (p = 0.04). Conclusions. MMF and tacrolimus could promote BKV viraemia after renal transplantation. Discontinuation of MMF together with a reduction of calcineurin inhibitors and glucocorticoids could be an option to reduce BKV replication after renal transplantation.Keywords
This publication has 30 references indexed in Scilit:
- Immunosuppressive agents as risk factors for BK virus nephropathy: an overview and updateExpert Opinion on Drug Safety, 2010
- Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant RecipientsAmerican Journal of Transplantation, 2009
- Polyomavirus nephropathy in native kidneys and renal allografts: an update on an escalating threatTransplant International, 2006
- BK virus nephritis after renal transplantationKidney International, 2006
- Polymerase Chain Reaction Detection of BK Virus and Monitoring of BK Nephropathy in Renal Transplant Recipients at the University Hospital La FeTransplantation Proceedings, 2005
- A Prospective Longitudinal Study of BK Virus Infection in 104 Renal Transplant RecipientsAmerican Journal of Transplantation, 2005
- Polyomavirus-Associated Nephropathy in Renal Transplantation: Interdisciplinary Analyses and RecommendationsTransplantation, 2005
- Incidence of BK with Tacrolimus Versus Cyclosporine and Impact of Preemptive Immunosuppression ReductionAmerican Journal of Transplantation, 2005
- Prospective Study of Polyomavirus Type BK Replication and Nephropathy in Renal-Transplant RecipientsThe New England Journal of Medicine, 2002
- NEW HUMAN PAPOVAVIRUS (B.K.) ISOLATED FROM URINE AFTER RENAL TRANSPLANTATIONThe Lancet, 1971